"Homozygote" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An individual in which both alleles at a given locus are identical.
Below are MeSH descriptors whose meaning is more general than "Homozygote".
Below are MeSH descriptors whose meaning is more specific than "Homozygote".
This graph shows the total number of publications written about "Homozygote" by people in Harvard Catalyst Profiles by year, and whether "Homozygote" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 19 | 20 |
1995 | 1 | 19 | 20 |
1996 | 1 | 29 | 30 |
1997 | 1 | 24 | 25 |
1998 | 2 | 26 | 28 |
1999 | 3 | 22 | 25 |
2000 | 4 | 19 | 23 |
2001 | 3 | 32 | 35 |
2002 | 0 | 35 | 35 |
2003 | 4 | 39 | 43 |
2004 | 1 | 40 | 41 |
2005 | 1 | 26 | 27 |
2006 | 1 | 26 | 27 |
2007 | 3 | 36 | 39 |
2008 | 3 | 52 | 55 |
2009 | 3 | 38 | 41 |
2010 | 4 | 32 | 36 |
2011 | 6 | 40 | 46 |
2012 | 5 | 33 | 38 |
2013 | 3 | 48 | 51 |
2014 | 4 | 35 | 39 |
2015 | 7 | 33 | 40 |
2016 | 6 | 44 | 50 |
2017 | 2 | 44 | 46 |
2018 | 3 | 26 | 29 |
2019 | 5 | 35 | 40 |
2020 | 10 | 38 | 48 |
2021 | 1 | 25 | 26 |
2022 | 0 | 19 | 19 |
2023 | 0 | 16 | 16 |
2024 | 0 | 3 | 3 |
Below are the most recent publications written about "Homozygote" by people in Profiles.
-
The immunopathological landscape of human pre-TCRa deficiency: From rare to common variants. Science. 2024 Mar; 383(6686):eadh4059.
-
Recombinant IFN-?1b Treatment in a Patient with Inherited IFN-? Deficiency. J Clin Immunol. 2024 Feb 16; 44(3):62.
-
Mutational analysis in different genes underlying severe combined immunodeficiency in seven consanguineous Pakistani families. Mol Biol Rep. 2024 Feb 14; 51(1):302.
-
Application of novel PACS-based informatics platform to identify imaging based predictors of CDKN2A allelic status in glioblastomas. Sci Rep. 2023 12 22; 13(1):22942.
-
Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma. Acta Neuropathol Commun. 2023 11 27; 11(1):186.
-
CHARR efficiently estimates contamination from DNA sequencing data. Am J Hum Genet. 2023 Dec 07; 110(12):2068-2076.
-
Influence of autozygosity on common disease risk across the phenotypic spectrum. Cell. 2023 10 12; 186(21):4514-4527.e14.
-
Copy number variation analysis in 138 families with steroid-resistant nephrotic syndrome identifies causal homozygous deletions in PLCE1 and NPHS2 in two families. Pediatr Nephrol. 2024 Feb; 39(2):455-461.
-
Novel homozygous variants in PRORP expand the genotypic spectrum of combined oxidative phosphorylation deficiency 54. Eur J Hum Genet. 2023 10; 31(10):1190-1194.
-
A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant. Neuropathol Appl Neurobiol. 2023 08; 49(4):e12928.